US Stock MarketDetailed Quotes

CHGCY Chugai Pharmaceutical (ADR)

Watchlist
  • 20.940
  • +0.310+1.50%
15min DelayClose Aug 9 15:59 ET
68.91BMarket Cap28.61P/E (TTM)

Chugai Pharmaceutical (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
49.54%168.53B
-1.91%110.14B
-19.57%462.72B
-27.20%117.72B
13.10%120.03B
4.50%112.7B
-43.76%112.28B
22.32%575.35B
4.27%161.71B
-20.34%106.13B
Change In working capital
-2,165.67%-111.07B
-64.48%44.11B
171.26%130.63B
106.41%12.76B
-78.36%-11.69B
-90.27%5.38B
474.55%124.19B
-120.53%-183.31B
-222.64%-198.86B
23.75%-6.56B
Cash from discontinued investing activities
Operating cash flow
-44.23%70.65B
-21.01%100.91B
68.29%409.93B
559.99%124.21B
24.25%31.3B
-26.72%126.67B
76.10%127.75B
-12.89%243.58B
-128.44%-27B
-69.16%25.19B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-17.48%-20.61B
51.08%-12.47B
14.58%-52.6B
96.35%-440M
-28.75%-9.12B
-112.11%-17.55B
25.40%-25.49B
5.16%-61.58B
-53.12%-12.05B
68.81%-7.09B
Net intangibles purchase and sale
-5.24%-1.08B
-100.42%-62M
258.96%12.85B
-854.55%-420M
75.69%-451M
71.15%-1.03B
664.09%14.75B
-17.21%-8.08B
-109.52%-44M
23.79%-1.86B
Net investment purchase and sale
-1,457.18%-119.55B
16.91%-20.57B
101.29%979M
160.60%6.07B
128.12%10.86B
129.17%8.81B
-1,005.71%-24.75B
-61.07%-76.08B
-7.51%-10.01B
-96,412.50%-38.61B
Net other investing changes
----
----
150.00%1M
--3M
---1M
---2M
200.00%1M
---2M
----
----
Cash from discontinued investing activities
Investing cash flow
-1,371.96%-140.65B
8.84%-32.24B
74.36%-37.29B
125.64%5.64B
104.20%1.99B
77.26%-9.56B
-4.09%-35.37B
-22.31%-145.47B
-28.25%-22.02B
-88.56%-47.45B
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance
-48.48%17M
-40.00%72M
-8.05%217M
381.82%53M
-57.69%11M
-37.74%33M
-17.81%120M
-24.84%236M
-80.00%11M
-38.10%26M
Cash dividends paid
-19.47%-540M
0.62%-64.96B
4.79%-131.59B
12.80%-368M
-5.40%-65.41B
22.20%-452M
13.03%-65.37B
-40.12%-138.22B
-31.88%-422M
-26.62%-62.06B
Net other financing activities
--2M
-200.00%-1M
---5M
---4M
-300.00%-2M
--0
200.00%1M
----
----
--1M
Cash from discontinued financing activities
Financing cash flow
-9.76%-2.6B
0.61%-66.87B
4.33%-139.33B
2.34%-2.3B
-5.32%-67.38B
2.95%-2.37B
12.47%-67.28B
-35.60%-145.64B
20.97%-2.36B
-25.34%-63.98B
Net cash flow
Beginning cash position
86.87%462.86B
106.45%458.67B
-17.02%222.17B
20.91%331.34B
1.31%365.02B
7.47%247.69B
-17.02%222.17B
26.10%267.75B
42.35%274.04B
92.54%360.31B
Current changes in cash
-163.26%-72.59B
-92.84%1.8B
590.92%233.3B
348.29%127.55B
60.46%-34.1B
-10.63%114.75B
165.51%25.1B
-189.18%-47.52B
-168.67%-51.37B
-1,680.12%-86.24B
Effect of exchange rate changes
35.49%3.49B
466.59%2.39B
65.14%3.2B
56.18%-220M
1,858.33%422M
79.78%2.58B
-59.07%422M
-8.88%1.94B
-218.12%-502M
66.20%-24M
End cash Position
7.87%393.76B
86.87%462.86B
106.45%458.67B
106.45%458.67B
20.91%331.34B
1.31%365.02B
7.47%247.69B
-17.02%222.17B
-17.02%222.17B
42.35%274.04B
Free cash flow
-54.84%48.41B
-12.11%88.38B
94.77%335.67B
371.70%105.99B
34.76%21.93B
-32.72%107.19B
181.26%100.56B
-16.65%172.34B
-144.78%-39.01B
-71.21%16.27B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations 49.54%168.53B-1.91%110.14B-19.57%462.72B-27.20%117.72B13.10%120.03B4.50%112.7B-43.76%112.28B22.32%575.35B4.27%161.71B-20.34%106.13B
Change In working capital -2,165.67%-111.07B-64.48%44.11B171.26%130.63B106.41%12.76B-78.36%-11.69B-90.27%5.38B474.55%124.19B-120.53%-183.31B-222.64%-198.86B23.75%-6.56B
Cash from discontinued investing activities
Operating cash flow -44.23%70.65B-21.01%100.91B68.29%409.93B559.99%124.21B24.25%31.3B-26.72%126.67B76.10%127.75B-12.89%243.58B-128.44%-27B-69.16%25.19B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale -17.48%-20.61B51.08%-12.47B14.58%-52.6B96.35%-440M-28.75%-9.12B-112.11%-17.55B25.40%-25.49B5.16%-61.58B-53.12%-12.05B68.81%-7.09B
Net intangibles purchase and sale -5.24%-1.08B-100.42%-62M258.96%12.85B-854.55%-420M75.69%-451M71.15%-1.03B664.09%14.75B-17.21%-8.08B-109.52%-44M23.79%-1.86B
Net investment purchase and sale -1,457.18%-119.55B16.91%-20.57B101.29%979M160.60%6.07B128.12%10.86B129.17%8.81B-1,005.71%-24.75B-61.07%-76.08B-7.51%-10.01B-96,412.50%-38.61B
Net other investing changes --------150.00%1M--3M---1M---2M200.00%1M---2M--------
Cash from discontinued investing activities
Investing cash flow -1,371.96%-140.65B8.84%-32.24B74.36%-37.29B125.64%5.64B104.20%1.99B77.26%-9.56B-4.09%-35.37B-22.31%-145.47B-28.25%-22.02B-88.56%-47.45B
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance -48.48%17M-40.00%72M-8.05%217M381.82%53M-57.69%11M-37.74%33M-17.81%120M-24.84%236M-80.00%11M-38.10%26M
Cash dividends paid -19.47%-540M0.62%-64.96B4.79%-131.59B12.80%-368M-5.40%-65.41B22.20%-452M13.03%-65.37B-40.12%-138.22B-31.88%-422M-26.62%-62.06B
Net other financing activities --2M-200.00%-1M---5M---4M-300.00%-2M--0200.00%1M----------1M
Cash from discontinued financing activities
Financing cash flow -9.76%-2.6B0.61%-66.87B4.33%-139.33B2.34%-2.3B-5.32%-67.38B2.95%-2.37B12.47%-67.28B-35.60%-145.64B20.97%-2.36B-25.34%-63.98B
Net cash flow
Beginning cash position 86.87%462.86B106.45%458.67B-17.02%222.17B20.91%331.34B1.31%365.02B7.47%247.69B-17.02%222.17B26.10%267.75B42.35%274.04B92.54%360.31B
Current changes in cash -163.26%-72.59B-92.84%1.8B590.92%233.3B348.29%127.55B60.46%-34.1B-10.63%114.75B165.51%25.1B-189.18%-47.52B-168.67%-51.37B-1,680.12%-86.24B
Effect of exchange rate changes 35.49%3.49B466.59%2.39B65.14%3.2B56.18%-220M1,858.33%422M79.78%2.58B-59.07%422M-8.88%1.94B-218.12%-502M66.20%-24M
End cash Position 7.87%393.76B86.87%462.86B106.45%458.67B106.45%458.67B20.91%331.34B1.31%365.02B7.47%247.69B-17.02%222.17B-17.02%222.17B42.35%274.04B
Free cash flow -54.84%48.41B-12.11%88.38B94.77%335.67B371.70%105.99B34.76%21.93B-32.72%107.19B181.26%100.56B-16.65%172.34B-144.78%-39.01B-71.21%16.27B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Japanese Companies
Japanese Companies
Intraday-0.04%